Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Start over
Modify criteria

Refine registrations results by

Status

Type

Subject matter

Government institutions

Refine monthly communication reports results by

Type

Subject matter of the communication

Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (171236)
Results: 1-50 | Export
  1. Aerospace Industries Association of Canada / Association des Industries Aérospatiales du Canada
    Type: In-house Organization
    Responsible officer: Michael Mueller, President & CEO
    Registration: 71 of 71 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 22
    Government institutions: 43
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 7
  2. Aerospace Industries Association of Canada / l’Association des industries aérospatiales du Canada
    Type: Consultant
    Lobbyist: William Yetman, Yetman Consulting
    Registration: 21 of 21 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 22
    Government institutions: 43
    Communication techniques: 3
    Government funding: Yes
  3. BASF Agricultural Solutions Canada Inc.
    Type: In-house Corporation
    Responsible officer: Leta LaRush, Vice President, Business Management
    Registration: 3 of 3 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 4
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  4. Algoma Steel Inc.
    Type: Consultant
    Lobbyist: Matthew Clark, Rubicon Strategy
    Registration: 6 of 6 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 5
    Government institutions: 17
    Communication techniques: 2
    Government funding: No
  5. AltaLink Management Ltd.
    Type: In-house Corporation
    Responsible officer: Paul Lee, President
    Registration: 37 of 37 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 13
    Government institutions: 21
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 8
  6. BASF Canada Inc.
    Type: In-house Corporation
    Responsible officer: Marian Van Hoek, President
    Registration: 43 of 43 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 7
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  7. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Dimitri Gitas, Country President
    Registration: 42 of 42 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 9
    Government institutions: 16
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1
  8. IQVIA Solutions Canada Inc.
    Type: In-house Corporation
    Responsible officer: Sylvia Durgerian, President
    Registration: 6 of 6 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 3
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  9. Hitachi Energy Canada Inc. / Hitachi Énergie Canada Inc.
    Type: In-house Corporation
    Responsible officer: Carla Vicente, Country Managing Director
    Registration: 2 of 2 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 4
  10. Canadian Energy Metals Corp.
    Type: Consultant
    Lobbyist: Kevin Doherty, Prairie Sky Strategy
    Registration: 9 of 9 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  11. Cegid Inc / Cegid inc.
    Type: In-house Corporation
    Responsible officer: Marc-André Nataf, Président
    Registration: 13 of 13 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  12. Champion Iron Limited
    Type: Consultant
    Lobbyist: Louis-Alexandre Lanthier, PAA Advisory | Conseils
    Registration: 6 of 6 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 3
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  13. Coalition for the Diversity of Cultural Expressions / Coalition pour la diversité des expressions culturelles
    Type: In-house Organization
    Responsible officer: Marie-Julie Desrochers, Directrice générale
    Registration: 11 of 11 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 3
    Government institutions: 8
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 1
  14. Nihtat Gwich'in Council
    Type: Consultant
    Lobbyist: Anshul Tipnis, Crestview Strategy
    Registration: 2 of 2 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  15. Rocky View County
    Type: Consultant
    Lobbyist: Anshul Tipnis, Crestview Strategy
    Registration: 5 of 5 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 5
    Government institutions: 6
    Communication techniques: 3
    Government funding: Yes
  16. Nisichawayasihk Cree Nation
    Type: Consultant
    Lobbyist: Grace Smith, Strategies North Advisory Inc.
    Registration: 6 of 6 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 2
    Government funding: Yes
  17. Dr. Reddy's Laboratories
    Type: Consultant
    Lobbyist: Sadaf Abbasi, Sussex Strategy Group
    Registration: 2 of 2 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  18. WILL SOLUTIONS / SOLUTIONS WILL
    Type: In-house Corporation
    Responsible officer: MARTIN CLERMONT, Président
    Registration: 8 of 8 (2026-05-19 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1
  19. Sagamok Anishnawbek First Nation
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 16 of 16 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 3
    Government funding: Yes
  20. Canadian Council for Sustainable Aviation Fuels / Conseil canadien des carburants d'aviation durables
    Type: In-house Organization
    Responsible officer: Geoff Tauvette, Executive Director
    Registration: 3 of 3 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 4
    Government institutions: 9
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 1
  21. Kahnawá:ke Shakotiia’takehnhas Community Services
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 8 of 8 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 3
    Government funding: Yes
  22. Munsee Delaware Nation
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 4 of 4 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 3
    Government funding: Yes
  23. Wasauksing First Nation
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 10 of 10 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 3
    Government funding: Yes
  24. Timiskaming First Nation
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 6 of 6 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: Yes
  25. Shawanaga First Nation
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 19 of 19 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: Yes
  26. Naicatchewanin First Nation
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 13 of 13 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 3
    Government funding: Yes
  27. Mitaanjigamiing First Nation
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 7 of 7 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 3
    Government funding: Yes
  28. Magnetawan First Nation
    Type: Consultant
    Lobbyist: Joshua Albert, The CCS Group
    Registration: 17 of 17 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 3
    Government funding: Yes
  29. Smart Procurement Group
    Type: Consultant
    Member of the organization: Kelly Hutchinson, Compass Rose Group
    Registration: 2 of 2 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 16
    Communication techniques: 3
    Government funding: No
  30. Tanium
    Type: Consultant
    Lobbyist: Kelly Hutchinson, Compass Rose Group
    Registration: 8 of 8 (2026-05-18 to present)
    Posted: 2026-05-19
    Subject matter details: 3
    Government institutions: 31
    Communication techniques: 2
    Government funding: No
  31. PATLON AIRCRAFT & INDUSTRIES LIMITED
    Type: Consultant
    Lobbyist: DAVE HATHERALL, CFN CONSULTANTS
    Registration: 3 of 3 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  32. Daewoo Shipbuilding & Marine Engineering Co. Ltd.
    Type: Consultant
    Lobbyist: DAVE HATHERALL, CFN CONSULTANTS
    Registration: 3 of 3 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 3
    Government funding: No
  33. Batchewana First Nation
    Type: Consultant
    Lobbyist: RON GERSH, TheCCSGroup
    Registration: 19 of 19 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 3
    Government institutions: 1
    Communication techniques: 3
    Government funding: Yes
  34. General Motors of Canada Company / Compagnie General Motors du Canada
    Type: Consultant
    Lobbyist: DAVE HATHERALL, CFN CONSULTANTS
    Registration: 6 of 6 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 3
    Government funding: Yes
  35. SRC Canada
    Type: Consultant
    Lobbyist: DAVE HATHERALL, CFN CONSULTANTS
    Registration: 3 of 3 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  36. Patriot Forge Co.
    Type: Consultant
    Lobbyist: Philip Cartwright, Global Public Affairs
    Registration: 7 of 7 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  37. Hanwha Defense USA Inc
    Type: Consultant
    Lobbyist: DAVE HATHERALL, CFN CONSULTANTS
    Registration: 4 of 4 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
  38. Wasauksing First Nation
    Type: Consultant
    Lobbyist: RON GERSH, TheCCSGroup
    Registration: 2 of 2 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
  39. Wauzhushk Onigum Nation
    Type: Consultant
    Lobbyist: RON GERSH, TheCCSGroup
    Registration: 2 of 2 (2026-05-17 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 3
    Government funding: Yes
  40. Quebec cannabis and hemp industry association / Association québécoise de l'industrie du chanvre et du cannabis
    Type: In-house Corporation
    Responsible officer: Pierre Leclerc, Président-directeur général
    Registration: 4 of 4 (2026-05-16 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 1
  41. SEMAPHOR.ai inc.
    Type: In-house Corporation
    Responsible officer: François Vaudrin, Président
    Registration: 19 of 19 (2026-05-16 to present)
    Posted: 2026-05-19
    Subject matter details: 3
    Government institutions: 6
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 1
  42. Canadian Institute of Steel Construction / Institut Canadien de la Construction en Acier
    Type: Consultant
    Lobbyist: Rob LeForte, First Lake Solutions
    Registration: 5 of 5 (2026-05-15 to present)
    Posted: 2026-05-19
    Subject matter details: 2
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  43. ACTRA Alliance of Canadian Cinema, Television and Radio Artists / ACTRA
    Type: Consultant
    Lobbyist: Deborah Owusu-Akyeeah, PAA Advisory | Conseils
    Registration: 2 of 2 (2026-05-15 to present)
    Posted: 2026-05-19
    Subject matter details: 5
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  44. Michelin North America (Canada) Inc.
    Type: In-house Corporation
    Responsible officer: Andrew Mutch, President
    Registration: 21 of 21 (2026-05-15 to present)
    Posted: 2026-05-19
    Subject matter details: 4
    Government institutions: 16
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 2
  45. American Chamber of Commerce in Canada
    Type: In-house Corporation
    Responsible officer: Richard Tachuk, President
    Registration: 2 of 2 (2026-05-15 to present)
    Posted: 2026-05-19
    Subject matter details: 12
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1
  46. Association québécoise des pharmaciens propriétaires (AQPP)
    Type: Consultant
    Lobbyist: Marc Desmarais, NATIONAL Public Relations
    Registration: 17 of 17 (2026-05-15 to present)
    Posted: 2026-05-15
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  47. Canadian Arts Coalition / Coalition Canadienne des Arts
    Type: Consultant
    Lobbyist: Deborah Owusu-Akyeeah, PAA Advisory | Conseils
    Registration: 2 of 2 (2026-05-15 to present)
    Posted: 2026-05-19
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 3
    Government funding: No
  48. Arts Umbrella
    Type: Consultant
    Lobbyist: Deborah Owusu-Akyeeah, PAA Advisory | Conseils
    Registration: 2 of 2 (2026-05-15 to present)
    Posted: 2026-05-19
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
  49. Prairies Arts Coalition
    Type: Consultant
    Lobbyist: Deborah Owusu-Akyeeah, PAA Advisory | Conseils
    Registration: 2 of 2 (2026-05-15 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  50. Performing Arts Consortium of Winnipeg (PAC)
    Type: Consultant
    Lobbyist: Deborah Owusu-Akyeeah, PAA Advisory | Conseils
    Registration: 2 of 2 (2026-05-15 to present)
    Posted: 2026-05-19
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
Monthly communication reports (98)
Results: 1-50 | Export
  1. Canadian Pharmaceutical Manufacturers and Exporters Alliance
    Type: Consultant
    Lobbyist: Terry Creighton
    Occurred: 2026-02-04
    Posted: 2026-03-16
    Designated public office holders:
    • Madeleine Chenette, Member of Parliament | House of Commons
    • Rodrigo Arancibia, Senior Director, HERC | Innovation, Science and Economic Development Canada (ISED)
    • Helena Jaczek, Member of Parliament | House of Commons
    • Guillaume Couillard, Director General | Patented Medicine Prices Review Board (PMPRB)
    • Doug Eyolfson, Member of Parliament | House of Commons
    • Jacques Ramsay, Member of Parliament, House of commons | House of Commons
    Subject matter details: 4
    Subject matters:
    • Health
    • International Trade
    • Taxation and Finance
    • Economic Development
      •
  2. Apotex Inc.
    Type: In-house Corporation
    Occurred: 2026-02-04
    Posted: 2026-02-26
    Designated public office holders:
    • Doug Eyolfson, Member of Parliament | House of Commons
    • Arianne Reza, Deputy Minister of Public Services and Procurement | Public Services and Procurement Canada (PSPC)
    • Helena Jaczek, Member of Parliament | House of Commons
    • Jacques Ramsay, Member of Parliament | House of Commons
    • Madeleine Chenette, Member of Parliament | House of Commons
    • Loris Mirella, Director - Intellectual Property Trade Policy | Global Affairs Canada (GAC)
    • Rodrigo Arancibia, Sr Director, Life Sciences | Innovation, Science and Economic Development Canada (ISED)
    • Guillaume Couillard, Director General | Patented Medicine Prices Review Board (PMPRB)
    Subject matter details: 2
    Subject matters:
    • Health
    • Intellectual Property
      •
  3. Pharmascience Inc.
    Type: In-house Corporation
    Occurred: 2026-02-04
    Posted: 2026-02-27
    Designated public office holders:
    • Guillaume Couillard, Directeur général | Patented Medicine Prices Review Board (PMPRB)
    • Kevin Pothier, Directeur principal, Politiques et de l'analyse économique | Patented Medicine Prices Review Board (PMPRB)
    Subject matter details: 1
    Subject matters:
    • Science and Technology
    • Taxation and Finance
    • Research and Development
    • Economic Development
      •
  4. McKesson Canada
    Type: In-house Corporation
    Occurred: 2025-07-30
    Posted: 2025-08-15
    Designated public office holders:
    • Guillaume Couillard, Director General | Patented Medicine Prices Review Board (PMPRB)
    Subject matter details: 1
    Subject matters:
    • Health
      •
  5. McKesson Canada
    Type: In-house Corporation
    Occurred: 2025-07-17
    Posted: 2025-08-04
    Designated public office holders:
    • Anie Perrault, Acting Chairperson | Patented Medicine Prices Review Board (PMPRB)
    Subject matter details: 1
    Subject matters:
    • Health
      •
  6. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2025-04-22
    Posted: 2025-05-09
    Designated public office holders:
    • Anie Perrault, Acting Chairperson | Patented Medicine Prices Review Board (PMPRB)
    Subject matter details: 2
    Subject matters:
    • Constitutional Issues
    • Consumer Issues
    • Health
    • Intellectual Property
    • International Relations
    • International Trade
    • Science and Technology
    • Taxation and Finance
    • Research and Development
    • Federal-Provincial Relations
    • Foreign Affairs
      •
  7. Lundbeck Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-09-06
    Posted: 2024-10-15
    Designated public office holders:
    • Thomas J. Digby, Chairperson | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Intellectual Property
      •
  8. RAREi - The Canadian Forum for Rare Disease Innovators / RAREi, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2024-08-08
    Posted: 2024-09-16
    Designated public office holders:
    • Guillaume Couillard, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
    • Science and Technology
    • Budget
    • Research and Development
      •
  9. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Occurred: 2024-08-08
    Posted: 2024-09-10
    Designated public office holders:
    • Guillaume Couillard, Director General | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
      •
  10. Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
    Type: In-house Organization
    Occurred: 2024-06-17
    Posted: 2024-07-15
    Designated public office holders:
    • Guillaume Couillard, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
      •
  11. Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
    Type: In-house Organization
    Occurred: 2024-05-01
    Posted: 2024-06-15
    Designated public office holders:
    • Guillaume Couillard, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
      •
  12. Québec Association of Pharmacy Distributors / Association québécoise des distributeurs en pharmacie
    Type: Consultant
    Lobbyist: Hugues Mousseau, Heyco Advisory Services Inc. / Cabinet conseil Heyco inc.
    Occurred: 2023-12-06
    Posted: 2023-12-08
    Designated public office holders:
    • Thomas Digby, Président, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Anie Perrault, Vice-présidente du Conseil, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Carolyn Kobernick, Membre du Conseil, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Guillaume Couillard, Directeur exécutif par intérim, Conseil | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  13. RAREi - The Canadian Forum for Rare Disease Innovators / RAREi, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2023-10-06
    Posted: 2023-11-15
    Designated public office holders:
    • Guillaume Couillard, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  14. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-07-21
    Posted: 2023-08-01
    Designated public office holders:
    • Thomas Digby, Chairperson | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
      •
  15. IQVIA Solutions Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-05-17
    Posted: 2023-05-18
    Designated public office holders:
    • Thomas Digby, Chairperson to the Patented Medicine Prices Review Board (PMPRB) | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  16. RAREi - The Canadian Forum for Rare Disease Innovators / RAREi, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-12-05
    Posted: 2023-01-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
    • International Trade
    • Science and Technology
    • Taxation and Finance
    • Economic Development
      •
  17. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Occurred: 2022-12-05
    Posted: 2022-12-09
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  18. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2022-11-29
    Posted: 2022-12-13
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  19. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-10-27
    Posted: 2022-11-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  20. Sun Life Financial Inc. / Financière Sun Life
    Type: In-house Corporation
    Occurred: 2022-10-19
    Posted: 2022-11-14
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  21. RAREi - The Canadian Forum for Rare Disease Innovators / RAREi, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-07-07
    Posted: 2022-08-15
    Designated public office holders:
    • Tanya Potashnik , Director of Policy and Economic Analysis | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
    • International Trade
    • Science and Technology
    • Taxation and Finance
    • Economic Development
      •
  22. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Occurred: 2022-07-07
    Posted: 2022-08-04
    Designated public office holders:
    • Tanya Potashnik, Director of Policy and Economic Analysis | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  23. Sun Life Financial Inc. / Financière Sun Life
    Type: In-house Corporation
    Occurred: 2022-06-10
    Posted: 2022-07-11
    Designated public office holders:
    • Douglas Clark , Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  24. The Canada Life Assurance Company / de la Compagnie d'Assurance du Canada sur la Vie
    Type: In-house Corporation
    Occurred: 2022-06-07
    Posted: 2022-07-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  25. GlaxoSmithKline Inc.
    Type: In-house Corporation
    Occurred: 2022-06-01
    Posted: 2022-06-30
    Designated public office holders:
    • Douglas Clark , Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  26. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-24
    Posted: 2022-06-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  27. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-04-14
    Posted: 2022-04-29
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
      •
  28. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-04-07
    Posted: 2022-05-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  29. Takeda Canada Inc.
    Type: Consultant
    Lobbyist: Ian Chesney, Santis Health
    Occurred: 2020-12-14
    Posted: 2020-12-14
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
    • Economic Development
      •
  30. Sunovion Pharmaceuticals Canada Inc.
    Type: Consultant
    Lobbyist: Kate Dalgleish, Compass Rose Group
    Occurred: 2020-12-09
    Posted: 2021-01-15
    Designated public office holders:
    • Elena Lungu, Manager, Policy Development | Patented Medicine Prices Review Board (PMPRB)
    • Isabel Jaen Raasch, General Counsel | Patented Medicine Prices Review Board (PMPRB)
    • Tanya Potashnik, Director, Policy & Economic Analysis Branch | Patented Medicine Prices Review Board (PMPRB)
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Research and Development
      •
  31. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-22
    Posted: 2020-11-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  32. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-07
    Posted: 2020-11-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  33. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Occurred: 2020-08-12
    Posted: 2020-09-09
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Intellectual Property
      •
  34. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-06-05
    Posted: 2020-07-14
    Designated public office holders:
    • Doug Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  35. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-05-15
    Posted: 2020-06-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Research and Development
      •
  36. Diabetes Canada / Diabète Canada
    Type: In-house Organization
    Occurred: 2020-01-22
    Posted: 2020-02-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  37. CANADIAN CANCER SOCIETY / Société canadienne du cancer
    Type: In-house Organization
    Occurred: 2019-12-10
    Posted: 2020-01-15
    Designated public office holders:
    • Douglas Clark, Executive Director, Exective Director's office | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  38. Takeda Canada Inc.
    Type: Consultant
    Lobbyist: Ian Chesney, Santis Health
    Occurred: 2019-07-29
    Posted: 2019-07-29
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Science and Technology
    • Budget
    • Research and Development
    • Economic Development
      •
  39. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-05-29
    Posted: 2019-06-11
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  40. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-03-07
    Posted: 2019-03-18
    Designated public office holders:
    • Douglas Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
    • Research and Development
      •
  41. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2018-12-11
    Posted: 2018-12-17
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    • Tanya Potashnick, Director | Patented Medicine Prices Review Board (PMPRB)
    • Matthew Kellison, Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  42. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-12-04
    Posted: 2019-01-13
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Economic Development
      •
  43. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-10-25
    Posted: 2018-11-01
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  44. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-09-11
    Posted: 2018-09-28
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  45. GlaxoSmithKline Inc.
    Type: In-house Corporation
    Occurred: 2018-06-28
    Posted: 2018-07-05
    Designated public office holders:
    • Doug Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
    • Economic Development
      •
  46. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2018-05-08
    Posted: 2018-09-07
    Designated public office holders:
    • Douglas Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Intellectual Property
    • Research and Development
    • Economic Development
      •
  47. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-04-10
    Posted: 2018-04-12
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  48. BIOTECANADA
    Type: In-house Organization
    Occurred: 2018-04-09
    Posted: 2018-05-23
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  49. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-03-07
    Posted: 2018-03-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  50. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-10-12
    Posted: 2017-11-15
    Designated public office holders:
    • Anju Dhillon, Member of Parliament - Dorval-Lachine-Lasalee | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
    • Science and Technology
    • Research and Development
      •
Date Modified: